Changes in Red Blood Cell membrane lipid composition: A new perspective into the pathogenesis of PKAN

Manar Aoun, Paola Antonia Corsetto, Guillaume Nugue, Gigliola Montorfano, Emilio Ciusani, David Crouzier, Penelope Hogarth, Allison Gregory, Susan Hayflick, Giovanna Zorzi, Angela Maria Rizzo, Valeria Tiranti

Research output: Contribution to journalArticle

Abstract

Pantothenate Kinase-Associated Neurodegeneration (PKAN) is a form of Neurodegeneration with Brain Iron Accumulation (NBIA) associated with mutations in the pantothenate kinase 2 gene (PANK2). The PANK2 catalyzes the first step of coenzyme A (CoA) biosynthesis, a pathway producing an essential cofactor that plays a key role in energy and lipid metabolism. The majority of PANK2 mutations reduces or abolishes the activity of the enzyme. In around 10% of cases with PKAN, the presence of deformed red blood cells with thorny protrusions in the circulation has been detected. Changes in membrane protein expression and assembly during erythropoiesis were previously explored in patients with PKAN. However, data on red blood cell membrane phospholipid organization are still missing in this disease. In this study, we performed lipidomic analysis on red blood cells from Italian patients affected by PKAN with a particular interest in membrane physico-chemical properties. We showed an increased number of small red blood cells together with membrane phospholipid alteration, particularly a significant increase in sphingomyelin (SM)/phosphatidylcholine (PC) and SM/phosphatidylethanolamine (PE) ratios, in subjects with PKAN. The membrane structural abnormalities were associated with membrane fluidity perturbation. These morphological and functional characteristics of red blood cells in patients with PKAN offer new possible tools in order to shed light on the pathogenesis of the disease and to possibly identify further biomarkers for clinical studies.

Original languageEnglish
Pages (from-to)180-189
Number of pages10
JournalMolecular Genetics and Metabolism
Volume121
Issue number2
DOIs
Publication statusPublished - Jun 1 2017

Fingerprint

Pantothenate Kinase-Associated Neurodegeneration
Membrane Lipids
Blood
Erythrocytes
Chemical analysis
Sphingomyelins
Cells
Membranes
Phospholipids
Genes
Mutation
Membrane Fluidity
Erythropoiesis
Coenzyme A
Phosphatidylcholines
Lipid Metabolism
Energy Metabolism
pantothenate kinase
Membrane Proteins
Fluidity

Keywords

  • Biomarkers
  • Erythrocytes
  • Membrane
  • Mitochondria
  • NBIA
  • Neurodegenerative diseases
  • Oxidized lipids
  • Phospholipids
  • PKAN

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Cite this

Changes in Red Blood Cell membrane lipid composition : A new perspective into the pathogenesis of PKAN. / Aoun, Manar; Corsetto, Paola Antonia; Nugue, Guillaume; Montorfano, Gigliola; Ciusani, Emilio; Crouzier, David; Hogarth, Penelope; Gregory, Allison; Hayflick, Susan; Zorzi, Giovanna; Rizzo, Angela Maria; Tiranti, Valeria.

In: Molecular Genetics and Metabolism, Vol. 121, No. 2, 01.06.2017, p. 180-189.

Research output: Contribution to journalArticle

Aoun, M, Corsetto, PA, Nugue, G, Montorfano, G, Ciusani, E, Crouzier, D, Hogarth, P, Gregory, A, Hayflick, S, Zorzi, G, Rizzo, AM & Tiranti, V 2017, 'Changes in Red Blood Cell membrane lipid composition: A new perspective into the pathogenesis of PKAN', Molecular Genetics and Metabolism, vol. 121, no. 2, pp. 180-189. https://doi.org/10.1016/j.ymgme.2017.04.006
Aoun, Manar ; Corsetto, Paola Antonia ; Nugue, Guillaume ; Montorfano, Gigliola ; Ciusani, Emilio ; Crouzier, David ; Hogarth, Penelope ; Gregory, Allison ; Hayflick, Susan ; Zorzi, Giovanna ; Rizzo, Angela Maria ; Tiranti, Valeria. / Changes in Red Blood Cell membrane lipid composition : A new perspective into the pathogenesis of PKAN. In: Molecular Genetics and Metabolism. 2017 ; Vol. 121, No. 2. pp. 180-189.
@article{36130b3525e742acadb5ecebd3fdd7b0,
title = "Changes in Red Blood Cell membrane lipid composition: A new perspective into the pathogenesis of PKAN",
abstract = "Pantothenate Kinase-Associated Neurodegeneration (PKAN) is a form of Neurodegeneration with Brain Iron Accumulation (NBIA) associated with mutations in the pantothenate kinase 2 gene (PANK2). The PANK2 catalyzes the first step of coenzyme A (CoA) biosynthesis, a pathway producing an essential cofactor that plays a key role in energy and lipid metabolism. The majority of PANK2 mutations reduces or abolishes the activity of the enzyme. In around 10{\%} of cases with PKAN, the presence of deformed red blood cells with thorny protrusions in the circulation has been detected. Changes in membrane protein expression and assembly during erythropoiesis were previously explored in patients with PKAN. However, data on red blood cell membrane phospholipid organization are still missing in this disease. In this study, we performed lipidomic analysis on red blood cells from Italian patients affected by PKAN with a particular interest in membrane physico-chemical properties. We showed an increased number of small red blood cells together with membrane phospholipid alteration, particularly a significant increase in sphingomyelin (SM)/phosphatidylcholine (PC) and SM/phosphatidylethanolamine (PE) ratios, in subjects with PKAN. The membrane structural abnormalities were associated with membrane fluidity perturbation. These morphological and functional characteristics of red blood cells in patients with PKAN offer new possible tools in order to shed light on the pathogenesis of the disease and to possibly identify further biomarkers for clinical studies.",
keywords = "Biomarkers, Erythrocytes, Membrane, Mitochondria, NBIA, Neurodegenerative diseases, Oxidized lipids, Phospholipids, PKAN",
author = "Manar Aoun and Corsetto, {Paola Antonia} and Guillaume Nugue and Gigliola Montorfano and Emilio Ciusani and David Crouzier and Penelope Hogarth and Allison Gregory and Susan Hayflick and Giovanna Zorzi and Rizzo, {Angela Maria} and Valeria Tiranti",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.ymgme.2017.04.006",
language = "English",
volume = "121",
pages = "180--189",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Changes in Red Blood Cell membrane lipid composition

T2 - A new perspective into the pathogenesis of PKAN

AU - Aoun, Manar

AU - Corsetto, Paola Antonia

AU - Nugue, Guillaume

AU - Montorfano, Gigliola

AU - Ciusani, Emilio

AU - Crouzier, David

AU - Hogarth, Penelope

AU - Gregory, Allison

AU - Hayflick, Susan

AU - Zorzi, Giovanna

AU - Rizzo, Angela Maria

AU - Tiranti, Valeria

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Pantothenate Kinase-Associated Neurodegeneration (PKAN) is a form of Neurodegeneration with Brain Iron Accumulation (NBIA) associated with mutations in the pantothenate kinase 2 gene (PANK2). The PANK2 catalyzes the first step of coenzyme A (CoA) biosynthesis, a pathway producing an essential cofactor that plays a key role in energy and lipid metabolism. The majority of PANK2 mutations reduces or abolishes the activity of the enzyme. In around 10% of cases with PKAN, the presence of deformed red blood cells with thorny protrusions in the circulation has been detected. Changes in membrane protein expression and assembly during erythropoiesis were previously explored in patients with PKAN. However, data on red blood cell membrane phospholipid organization are still missing in this disease. In this study, we performed lipidomic analysis on red blood cells from Italian patients affected by PKAN with a particular interest in membrane physico-chemical properties. We showed an increased number of small red blood cells together with membrane phospholipid alteration, particularly a significant increase in sphingomyelin (SM)/phosphatidylcholine (PC) and SM/phosphatidylethanolamine (PE) ratios, in subjects with PKAN. The membrane structural abnormalities were associated with membrane fluidity perturbation. These morphological and functional characteristics of red blood cells in patients with PKAN offer new possible tools in order to shed light on the pathogenesis of the disease and to possibly identify further biomarkers for clinical studies.

AB - Pantothenate Kinase-Associated Neurodegeneration (PKAN) is a form of Neurodegeneration with Brain Iron Accumulation (NBIA) associated with mutations in the pantothenate kinase 2 gene (PANK2). The PANK2 catalyzes the first step of coenzyme A (CoA) biosynthesis, a pathway producing an essential cofactor that plays a key role in energy and lipid metabolism. The majority of PANK2 mutations reduces or abolishes the activity of the enzyme. In around 10% of cases with PKAN, the presence of deformed red blood cells with thorny protrusions in the circulation has been detected. Changes in membrane protein expression and assembly during erythropoiesis were previously explored in patients with PKAN. However, data on red blood cell membrane phospholipid organization are still missing in this disease. In this study, we performed lipidomic analysis on red blood cells from Italian patients affected by PKAN with a particular interest in membrane physico-chemical properties. We showed an increased number of small red blood cells together with membrane phospholipid alteration, particularly a significant increase in sphingomyelin (SM)/phosphatidylcholine (PC) and SM/phosphatidylethanolamine (PE) ratios, in subjects with PKAN. The membrane structural abnormalities were associated with membrane fluidity perturbation. These morphological and functional characteristics of red blood cells in patients with PKAN offer new possible tools in order to shed light on the pathogenesis of the disease and to possibly identify further biomarkers for clinical studies.

KW - Biomarkers

KW - Erythrocytes

KW - Membrane

KW - Mitochondria

KW - NBIA

KW - Neurodegenerative diseases

KW - Oxidized lipids

KW - Phospholipids

KW - PKAN

UR - http://www.scopus.com/inward/record.url?scp=85018671299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018671299&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2017.04.006

DO - 10.1016/j.ymgme.2017.04.006

M3 - Article

AN - SCOPUS:85018671299

VL - 121

SP - 180

EP - 189

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 2

ER -